Rinvoq (upadacitinib)

£1,559.25

Rinvoq (upadacitinib) is a medication used to treat adults with active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and ankylosing spondylitis.

DISEASE INDICATIONS

Psoriatic Arthritis, Rheumatoid Arthritis

MANUFACTURER

AbbVie Ltd

USAGE

Oral

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

  • Pharmaceuticals and Medical Devices Agency (PMDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

    WE CAN HELP WITH YOUR IMPORT DOCUMENTS

    We are experts in import regulations.

This content has been reviewed by a Medical Doctor.
RINVOQ (UPADACITINIB) Package 30 tablets

30 extended-release tablets of 15 mg

Reviews

There are no reviews yet.

Be the first to review “Rinvoq (upadacitinib)”

Your email address will not be published. Required fields are marked *

Shopping Cart